Ghost Tree Capital’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Ghost Tree Capital’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-300,000	Closed	-$7.99M	–	64
2018 Q3	$7.99M	Buy	+300,000	New	+$9.79M	1.7%	23
2018 Q1	–	Sell	-225,000	Closed	-$11M	–	71
2017 Q4	$11M	Buy	+225,000	New	+$11.4M	2.57%	11
2017 Q3	–	Sell	-200,000	Closed	-$11.2M	–	84
2017 Q2	$11.2M	Hold	200,000	–	–	2.34%	13
2017 Q1	$7.84M	Buy	+200,000	New	+$6.37M	1.46%	30
2016 Q2	–	Sell	-40,000	Closed	-$816K	–	86
2016 Q1	$816K	Sell	40,000 -190,000	-83%	-$6.03M	0.46%	42
2015 Q4	$11.8M	Buy	230,000 +205,000	+820%	+$9.94M	4.85%	4
2015 Q3	$1.07M	Sell	25,000 -145,000	-85%	-$7M	0.48%	58
2015 Q2	$7.74M	Sell	170,000 -10,000	-6%	-$402K	2.51%	11
2015 Q1	$6.83M	Buy	180,000 +30,000	+20%	+$1.03M	2.46%	11
2014 Q4	$4.25M	Buy	150,000 +35,000	+30%	+$973K	2.04%	19
2014 Q3	$2.91M	Buy	+115,000	New	+$3.03M	1.58%	29

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ghost Tree Capital's PTLA Position: Q4 2018 in Review

Ghost Tree Capital sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2018, closing a stake of 300,000 shares — an estimated $7.99M sold.

Ghost Tree Capital first reported a position in PTLA in Q3 2014 and held it in 11 quarters. The position peaked at $11.8M in Q4 2015. 181 funds tracked by Wall St. Rank hold PTLA as of Q4 2018.

Ghost Tree Capital reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
Ghost Tree Capital sold 300,000 Portola Pharmaceuticals, Inc. shares in Q4 2018, an estimated $7.99M.
Ghost Tree Capital first reported a position in Portola Pharmaceuticals, Inc. in Q3 2014 and held it in 11 quarters.
Ghost Tree Capital's Portola Pharmaceuticals, Inc. position peaked at $11.8M in Q4 2015.
181 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2018.

Based on Ghost Tree Capital's 13F filing for Q4 2018, filed 14 Feb 2019.